Skip to main content
Fig. 2 | Breast Cancer Research

Fig. 2

From: Correction to: Intracellular hypoxia measured by F-18 fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen-receptor positive breast (BRCR-D17-00693)

Fig. 2

Survival curves. a Disease-free survival (DFS). b Overall survival (OS). c DFS stratified by estrogen receptor (ER) status. d OS stratified by ER status. The tentative cutoff value of 1.48 separates tumors with higher 18F-fluoromisonidazole tissue-to-blood ratio (TBR high) from those with lower 18F-fluoromisonidazole tissue-to-blood ratio (TBR low)

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us